share_log

Peeling Back The Layers: Exploring Biogen Through Analyst Insights

Peeling Back The Layers: Exploring Biogen Through Analyst Insights

揭開面紗:通過分析師洞察探索渤健公司
Benzinga ·  11/14 10:00

Throughout the last three months, 18 analysts have evaluated Biogen (NASDAQ:BIIB), offering a diverse set of opinions from bullish to bearish.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings75600
Last 30D00100
1M Ago42300
2M Ago12200
3M Ago21000

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $249.94, along with a high estimate of $300.00 and a low estimate of $180.00. Observing a downward trend, the current average is 6.41% lower than the prior average price target of $267.06.

bigjpg

Exploring Analyst Ratings: An In...

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論